112 related articles for article (PubMed ID: 2778256)
1. Control of nephrotoxicity in the rat during repeated cis-platinum treatments.
Jones MM; Basinger MA
J Appl Toxicol; 1989 Aug; 9(4):229-33. PubMed ID: 2778256
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
Jones MM; Basinger MA; Mitchell WM; Bradley CA
Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
[TBL] [Abstract][Full Text] [Related]
3. Dithiocarbamate-induced biliary platinum excretion and the control of cis-platinum nephrotoxicity.
Basinger MA; Jones MM; Gilbreath SG; Walker EM; Fody EP; Mayhue MA
Toxicol Appl Pharmacol; 1989 Feb; 97(2):279-88. PubMed ID: 2538006
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
DeWoskin RS; Riviere JE
Toxicol Appl Pharmacol; 1992 Feb; 112(2):182-9. PubMed ID: 1311464
[TBL] [Abstract][Full Text] [Related]
5. Control of some aspects of cis-platinum nephrotoxicity.
Jones MM; Basinger MA; Craft WD; Domingo JL; Llobet JM
Arch Toxicol; 1986 Oct; 59(3):167-71. PubMed ID: 3028320
[TBL] [Abstract][Full Text] [Related]
6. Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.
Saito Y; Okamoto K; Kobayashi M; Narumi K; Furugen A; Yamada T; Iseki K
Life Sci; 2017 Nov; 189():18-22. PubMed ID: 28864226
[TBL] [Abstract][Full Text] [Related]
7. The prevention of cisplatin-induced renal dysfunction by hydroxyl-containing dithiocarbamates.
Reznik LV; Myazina EM; Shakchmatova EI; Gambaryan SP; Brovtsyn VK; Natochin YV; Jones MM
Br J Cancer; 1991 Feb; 63(2):234-6. PubMed ID: 1847647
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of diethyldithiocarbamate and N-benzyl-D-glucamine dithiocarbamate on cis-diamminedichloroplatinum-induced toxicity in kidney and gastrointestinal tract in rats.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
J Appl Toxicol; 1995; 15(4):267-73. PubMed ID: 7594195
[TBL] [Abstract][Full Text] [Related]
9. The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments.
Yajima Y; Kawaguchi M; Yoshikawa M; Okubo M; Tsukagoshi E; Sato K; Katakura A
J Pharmacol Sci; 2017 Jun; 134(2):108-115. PubMed ID: 28648300
[TBL] [Abstract][Full Text] [Related]
10. Effects of sodium thiosulfate on the pharmacokinetics of unchanged cisplatin and on the distribution of platinum species in rat kidney: protective mechanism against cisplatin nephrotoxicity.
Nagai N; Hotta K; Yamamura H; Ogata H
Cancer Chemother Pharmacol; 1995; 36(5):404-10. PubMed ID: 7634382
[TBL] [Abstract][Full Text] [Related]
11. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
Zhang JS; Imai T; Otagiri M
Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
[TBL] [Abstract][Full Text] [Related]
12. The effect of heavy metal chelators on the renal accumulation of platinum after cis-dichlorodiammineplatinum II administration to the rat.
Graziano J; Jones B; Pisciotto P
Br J Pharmacol; 1981 Jul; 73(3):649-54. PubMed ID: 6265016
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro study.
Hannemann J; Baumann K
Arch Toxicol; 1990; 64(5):393-400. PubMed ID: 2169720
[TBL] [Abstract][Full Text] [Related]
14. Relative effectiveness of some compounds for the control of cisplatin-induced nephrotoxicity.
Jones MM; Basinger MA; Holscher MA
Toxicology; 1991; 68(3):227-47. PubMed ID: 1896997
[TBL] [Abstract][Full Text] [Related]
15. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Osman NM; Copley MP; Litterst CL
Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
[TBL] [Abstract][Full Text] [Related]
16. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
Hanada K; Odaka K; Kudo A; Ogata H
Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity].
Kubota A; Yoshida T; Tsukuda M; Furukawa S; Miyata K; Mochimatsu I; Sawaki S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2599-605. PubMed ID: 2774590
[TBL] [Abstract][Full Text] [Related]
18. Studies on nephrotoxicity following a single and repeated administration of cis-diamminedichloroplatinum (CDDP) in rats.
Mizushima Y; Nagahama H; Yokoyama A; Morikage T; Yano S
Tohoku J Exp Med; 1987 Feb; 151(2):129-35. PubMed ID: 3576612
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of N-benzyl-D-glucamine dithiocarbamate against renal toxicity in rats during repeated cis-diamminedichloroplatinum administrations.
Hidaka S; Funakoshi T; Shimada H; Tsuruoka M; Kojima S
Ren Fail; 1995 Sep; 17(5):539-50. PubMed ID: 8570866
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of dithiocarbamates against renal toxicity of cis-diamminedichloroplatinum in rats.
Hidaka S; Tsuruoka M; Funakoshi T; Shimada H; Kiyozumi M; Kojima S
Ren Fail; 1994; 16(3):337-49. PubMed ID: 8059017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
